javelin merkel 200: avelumab for metastatic merkel cell carcinoma
Published 5 years ago • 246 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
2:38
long-term follow-up results from javelin merkel 200 and keynote-017 in mcc
-
2:31
javelin merkel 200: two year update of pivotal trial data in metastatic merkel cell carcinoma
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
1:28
avelumab treatment in patients with metastatic merkel cell carcinoma
-
2:19
chemotherapy vs. immunotherapy for the treatment of merkel cell carcinoma
-
1:09
new standard of care for merkel cell carcinoma
-
1:53
new treatment approaches for merkel cell carcinoma - checkpoint inhibitors
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:37
avelumab for treatment of metastatic merkel cell carcinoma
-
1:36
what is the mechanism behind merkel cell carcinoma development
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
2:26
nivolumab and ipilimumab in advanced merkel cell carcinoma
-
2:09
can merkel cell carcinoma be treated with a cancer vaccine
-
2:03
avelumab in merkel cell carcinoma – updates from asco 2017
-
1:08
novel approaches in treating merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
2:18
durable responses to avelumab in patients with merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma